Market Reports

IntelGenx: oral films are drug development’s patent trick

IntelGenx: oral films are drug development’s patent trick

Exploiting improvements in bioavailability, the Canadian company has developed unique oral film technology to help drugmakers secure exclusivity and financial returns
How to avoid sticking and picking in the tableting industry

How to avoid sticking and picking in the tableting industry

John Norman and Kevin Queensen of Natoli Engineering explain
Super early bird tickets now on sale for Manufacturing Chemist Live 2020

Super early bird tickets now on sale for Manufacturing Chemist Live 2020

Manufacturing Chemist Live will provide guidelines and regulations for delegates seeking solutions to optimise pharmaceutical production and safety in the manufacturing environment
Distributed control system reduces downtime for pharmaceutical manufacturer

Distributed control system reduces downtime for pharmaceutical manufacturer

In this case study, Rockwell Automation describes how Mallinckrodt Pharmaceuticals was able to streamline production and pinpoint potential bottlenecks by implementing a virtualised control system architecture
Flexibility through standardisation

Flexibility through standardisation

The global pharmaceutical industry is going through a significant transformation, shifting from blockbuster drugs to personalised medicines based on biotechnology and genomics
There’s more than one way to produce pharmaceutical water

There’s more than one way to produce pharmaceutical water

Bosch Packaging’s Susanne Handrick and Nils Ern examine the potential of cold membrane processes for the production of pharmaceutical water for injection
Winner of the Nobel Prize in Physiology or Medicine

Winner of the Nobel Prize in Physiology or Medicine

William Kaelin Jr, Sir Peter Ratcliffe, and Gregg Semenza have won the Nobel Prize for Physiology or Medicine 2019 for their discoveries of how cells sense and adapt to oxygen availability
Medical cannabis made in Italy

Medical cannabis made in Italy

Dr Fabio Di Francesco, a compounding pharmacist based in Rome, describes how cannabis is used in various dosage forms and the challenges ahead
Almac FAST: Continuous flow chemistry with assisted synthesis technology

Almac FAST: Continuous flow chemistry with assisted synthesis technology

Flow assisted synthesis technology (FAST) is a unique flow chemistry platform for continuous production of chemicals when batch-based processes fail to deliver the required quality of product
Peak identification by LC/MS: Automation versus analyst

Peak identification by LC/MS: Automation versus analyst

High pressure liquid chromatography/mass spectrometry (LC/MS) is an important technique that facilitates the correct and accurate identification of impurities in pharmaceutical products and intermediates
Testing the limits of dosage production with continuous direct compression technology

Testing the limits of dosage production with continuous direct compression technology

GEA’s Dr James Holman, Head of New Development and Innovation, Pharma, discusses the process robustness and operational considerations of the company’s CDC 50 platform during a 120-hour trial run
Beximco Pharma: The Bangladeshi company connecting with the US

Beximco Pharma: The Bangladeshi company connecting with the US

COO Rabbur Reza talks about the strategy behind approaching pharmaceutical manufacturing from an emerging market
Addressing the need for cost-effective vaccine manufacturing

Addressing the need for cost-effective vaccine manufacturing

Process intensification and integrated continuous bioprocessing are two approaches that can be used to achieve cost-effective, local production of high-quality biologic products. Tania Pereira-Chilima, Product Manager at Univercells, explains
Future market dynamics and opportunities in immuno-oncology

Future market dynamics and opportunities in immuno-oncology

Long-term survival, tumour-agnostic effects and the potential for cure in a fraction of patients are key catalysts driving the explosion of research and recent approvals in IO. Dr Kevin Robinson recently caught up with SmartAnalyst’s Nidhi Dhingra and Jaideep V. Thottassery to delve a little deeper
A microfluidic approach to production of alginate beads for cell encapsulation

A microfluidic approach to production of alginate beads for cell encapsulation

Gurinder Vinner, Material Scientist at Dolomite Microfluidics, discusses the benefits of continuous microfluidic production for the encapsulation of mammalian cells with no loss of viability
The case for single-use architecture in pharma

The case for single-use architecture in pharma

Billy Sisk, Life Sciences Industry Manager, EMEA, at Rockwell Automation recently contributed to the free downloadable e-book, the <i>Big Book of Biotech</i>, alongside input from GSK, Merck, ZeClinics and others. Here, for readers of <i>Manufacturing Chemist</i>, he picks up his topic of single-use facilities

Trending Articles

  1. A rules-based approach to labelling and artwork management: Part I Many organisations today are experiencing unprecedented demands from regulatory authorities and consumers alike for product labelling to be made clearer and more informative, says Graham Francis, Channel Marketing Manager, Kallik
  2. A microfluidic approach to production of alginate beads for cell encapsulation Gurinder Vinner, Material Scientist at Dolomite Microfluidics, discusses the benefits of continuous microfluidic production for the encapsulation of mammalian cells with no loss of viability
  3. Recombinant versus synthetic peptide synthesis: the perks and drawbacks Since the introduction of novel peptide drugs into the market, the demand for polypeptide manufacturing has significantly increased, reports Dr Philipp Markolin
  4. UK pharma shifts as Merck and AstraZeneca scale back: can CDMOs fill the gap? Recent major site withdrawals and investment pauses have raised concerns about the UK’s industrial strength. But CDMOs say agility, innovation and technical expertise could redefine how and where drugs are made
  5. CMC strategies for the acceleration of commercial-ready ADC manufacturing The potential for antibody-drug conjugate (ADC) programmes to accelerate from early to late stage clinical development highlights the need to establish commercial launch-ready manufacturing early and efficiently, reports Courtney Morgret, Senior Scientist, Manufacturing Sciences, AbbVie

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all